Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | EMB-01 |
| Synonyms | |
| Therapy Description |
EMB-01 is a bispecific antibody targeting EGFR and MET, which potentially inhibits tumor growth (Cancer Res (2025) 85 (8_Supplement_2): CT168). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| EMB-01 | EMB01|FIT-013a|EMB 01|Bafisontamab | EGFR Antibody 72 MET Antibody 37 | EMB-01 is a bispecific antibody targeting EGFR and MET, which potentially inhibits tumor growth (Cancer Res (2025) 85 (8_Supplement_2): CT168). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT05176665 | Phase Ib/II | EMB-01 | EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers | Recruiting | USA | 1 |
| NCT03797391 | Phase Ib/II | EMB-01 | A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors | Recruiting | USA | 1 |